Clinical Trial: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Hematopoietic Stem Cell Transplantation Using Alternate Donor Umbilical Cord Blood Options

Brief Summary: This study will determine the safety and applicability of experimental forms of umbilical cord blood (UCB) transplantation for patients with high risk hematologic malignancies who might benefit from a hematopoietic stem cell transplant (HSCT) but who do not have a standard donor option (no available HLA-matched related donor (MRD), HLA-matched unrelated donor (MUD)), or single UCB unit with adequate cell number and HLA-match).